Chester County News and Community Website
EXTON, PA — AbbVie (NYSE: ABBV) and Immunome, Inc. (Nasdaq: IMNM) recently announced a worldwide collaboration and option agreement directed to the discovery of up to 10 novel antibody-target pairs arising from three …
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets Read More EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) recently announced the first patient has been enrolled in a clinical trial of IMM-BCP-01, a three-antibody cocktail for the treatment of SARS-CoV-2 (COVID-19). …
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19 Read More
WASHINGTON, D.C. — The following quote is attributed to Tim Stenzel, M.D., Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices …
FDA Advises Against Use of Antibody Test to Evaluate Immunity or Protection From COVID-19, Including After Vaccination Read More